Contact
Novartis Pharma NV/SA:
+ 32 (0)2 246 16 11
In geval van een bijwerking:
[email protected]
Tel 24/24u:
Bel: 0800 94 368
Lux: +32475319792
McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. They have evolved over time and it is anticipated that, in 2025, newly revised diagnostic criteria will become available for MS1,2.
Healthcare professionals: register now to access up-to-date information about MS treatment.